Latvian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
International Journal of Surgery Case Reports 2016

Synchronous thymoma and oligodendroglioma: A rare association.

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
Saite tiek saglabāta starpliktuvē
Mohammad Vaziri
Kamelia Rad

Atslēgvārdi

Abstrakts

BACKGROUND

Patients with thymoma are found to have another systemic illness and a broadly increased risk for secondary malignancies. We present the case of a 53-year-old female patient who harbored two synchronous primary malignant neoplasms-an anaplastic oligodendroglioma of the right frontal lobe and an anterior mediastinal thymoma.

METHODS

A 53-year-old female patient presented in her first hospital admission with nausea, chest pain and non-pulsatile bitemporal headache. Continued headache and nausea along with negative cardiac findings prompted radiological evaluation including chest CT scan and brain CT scan which revealed simultaneous anterior mediastinal mass and frontal lobe calcification respectively. The patient underwent craniotomy and the pathological diagnosis was anaplastic oligodendriglioma. The anterior mediastinal tumor resection was performed three months later, while the patient had no newly onset of any symptoms necessitating more investigation.

CONCLUSIONS

Multiple primary malignancies have been diagnosed by the following criteria: each tumor must have an obvious picture of malignancy, each must be separate and discrete and the probability that one was a metastatic lesion from the other must be excluded. Treatment strategies in cases of double malignancy involve treating the malignancy that is more advanced first. In our case we concluded that synchronous double malignancy can be treated successfully according to the above mentioned criteria.

CONCLUSIONS

Clinicians should be aware of the possibility of synchronous malignancies in order to use screening procedures in patients with reported increased risk of double malignancy. Such clinical alertness may lead to a better outcome for double primary tumor cases.

Pievienojieties mūsu
facebook lapai

Vispilnīgākā ārstniecības augu datu bāze, kuru atbalsta zinātne

  • Darbojas 55 valodās
  • Zāļu ārstniecības līdzekļi, kurus atbalsta zinātne
  • Garšaugu atpazīšana pēc attēla
  • Interaktīva GPS karte - atzīmējiet garšaugus atrašanās vietā (drīzumā)
  • Lasiet zinātniskās publikācijas, kas saistītas ar jūsu meklēšanu
  • Meklēt ārstniecības augus pēc to iedarbības
  • Organizējiet savas intereses un sekojiet līdzi jaunumiem, klīniskajiem izmēģinājumiem un patentiem

Ierakstiet simptomu vai slimību un izlasiet par garšaugiem, kas varētu palīdzēt, ierakstiet zāli un redziet slimības un simptomus, pret kuriem tā tiek lietota.
* Visa informācija ir balstīta uz publicētiem zinātniskiem pētījumiem

Google Play badgeApp Store badge